Cytek BioSciences Inc (CTKB) Company Profile & Statistics

Cytek BioSciences Inc
CTKB
(Nasdaq - US)
N/A
6.42
+0.20 (+3.13%)
in:usd•As of: May 06, 2024 15:59 UTC -4
Open
6.32
High
6.46
Low
6.29

About Cytek BioSciences Inc

CEO

Wenbin Jiang

Headquarters

47215 lakeview blvd.

fremont, ca 94538, united states

Auditor

Deloitte & Touche LLP

Employees

676

Share Holders

Website

https://cytekbio.com

Industry

medical specialties

Sector

health technology

Company Overview

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

Cytek BioSciences Inc Statistics

Valuation Measures

Market Capitalization ²	842.03M
Enterprise Value	676.05M
Enterprise Value/EBITDA (ttm)	-36.32
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.14
Price to Sales (ttm)	4.23
Price to Cash (ytd)	246.60

Profitability

Gross Margin (ttm)	56.69%
Operating Margin (ttm)	-3.01%
Profit Margin (ttm)	-7.80%
Return on Equity (ttm)	-1.40%
Return on Invested Capital (ttm)	-2.78%
Return on Assets (ttm)	-1.13%

Income Statement

Revenue (ttm)	193.01M
Revenue Per Share (ttm)	1.48
Gross Profit (ttm)	109.43M
EBITDA (ttm)³	-18.62M
Net Income Avi to Common (ttm)	-12.15M
Diluted EPS (ttm)	-0.09

Share Statistics

Beta (5Y Monthly)	1.38
52-Week Change	-44.70%
S&P500 52-Week Change	27.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	130.82M
Dividend Yield	0.00%
Float ⁴	110.39M
% Held by Insiders	15.90%
% Held by Institutions	69.46%

Balance Sheet

Total Cash (mrq)	262.74M
Total Cash Per Share (mrq)	2.01
Total Debt (mrq)	1.65M
Total Debt/Equity (mrq)	0.42%
Current Ratio (mrq)	6.97%
Quick Ratio (mrq)	5.89%
Book Value Per Share (mrq)	3.01

Cash Flow

Operating Cash Flow Per Share (ytd)	0.04
Free Cash Flow (ytd)	633.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Cytek BioSciences Inc

Trade With A Regulated Broker